• 1
    Grob P.J., Joller-Jemelka H.I., Fortschritte in der Hepatitisdiagnostik, Schweiz. Rundschau für Medizin (Praxis), 19: 547554, 1995.
  • 2
    Santantonio T., Jung M.C., Miska S., Pastore G., Pape G.R., Will H., Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area, Virology, 183: 840844, 1991.
  • 3
    Chu C.M., Yeh C.T., Chiu C.T., Sheen I.S., Liaw Y.F., Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which heptatits B is endemic, J. Clin. Microbiol., 7: 18151818, 1996.
  • 4
    Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., Okamoto H., et al., Hepatitis B virus escape mutants: “Pushing the envelope” of chronic hepatitis B virus infection, Hepatology, 3: 1995, 884887, 1995.
  • 5
    Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A.J., Thomas H.C., Vaccine-induced escape mutant of hepatitis B virus, Lancet, 336: 325329, 1990.
  • 6
    Kohno H., Inoue T., Tsuda F., Okamoto H., Akahane Y., Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hapatitis B, J. Gen. Virol., 77: 18251831, 1996.
  • 7
    Blum H.E., Variants of hepatitis B, C and D viruses: Molecular biology and clinical significance, Digestion, 56: 8595, 1995.
  • 8
    Santantonio T., Jung M.C., Schneider R., Pastore G., Pape G.R., Will H., Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment, J. Hepatol., 3: 368371, 1991.
  • 9
    Löhr H.F., Weber W., Schlaak J., Goergen B., Meyer zum Büschenfelde K.H., Gerken G., Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants, Hepatology, 1: 6168, 1995.
  • 10
    Laskus T., Rakela J., Persing D.H., Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interfernon, Dig. Dis. Sci., 1: 17, 1995.
  • 11
    Bartholomew M.M., Jansen R.W., Jeffers L.J., Reddy K.R., Johnson L.C., Bunzendahl H., Condreay L.D., Tzakis A.G., Schiff E.R., Brown N.A., Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver tranplantation, Lancet, 349: 2022, 1997.
  • 12
    Lee Y.I., Hur G.M., Suh D.J., Kim S.H., Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants, J. Gen. Virol., 77: 11291138, 1996.
  • 13
    Günther S., Baginski S., Kissel H., Reinke P., Krüger D.H., Will H., Meisel H., Accumulation and persistence of hepatitits B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease, Hepatology, 4: 751758, 1996.
  • 14
    Guptan R.C., Thakur V., Sarin S.K., Banerjee K., Khandekar P., Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease, A. J. G., 7: 13121317, 1996.
  • 15
    Günther S., Li B.C., Miska S., Krüger D.H., Meisel H., Will H., A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients, J. Virol., 9: 54375444, 1995.
  • 16
    Hosono S., Tai P.C., Wang W., Ambrose M., Hwang D.G.Y., Yuan T.T., Peng B.H., Yang C.S., Lee C.S., Shih C., Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes, Virology, 212: 151162, 1995.
  • 17
    Wang X.W., Forrester K., Yeh H., Feitelson M.A., Gu J.R., Harris C.C., Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3, Proc. Natl. Acad. Sci. USA, 91: 22302234, 1994.
  • 18
    Takada S., Koike K., Trans-activation function of a 3 ' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues, Proc. Natl. Acad. Sci. USA, 15: 56285632, 1990.
  • 19
    Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P., Nucleotide sequence of the hepatitis B virus genome (subtyp ayw) cloned in e. coli, Nature, 281: 646650, 1979.
  • 20
    Tiollais P., Pourcel C., Dejean A., The hepatitis B virus, Nature, 317: 489495, 1985.
  • 21
    Norder H., Couroucé A.M., Magnius L.O., Molecular basis of hepatitis B virus serotype variations within the four major subtypes, J. Gen. Virol., 73: 31413145, 1992.
  • 22
    Ohnuma H., Machida A., Okamoto H., Tsuda F., Sakamoto M., Tanaka T., Miyakawa Y., Mayumi M., Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r, J. Virol., 2: 927932, 1993.
  • 23
    Kidd-Ljunggren K., Variability in hepatitis B virus DNA: Phylogenetic, epidemiological and clinical implications, Scand. J. Infect. Dis., 2: 111116, 1996.
  • 24
    Courouce-Pauty A.M., Plancon A., Soulier J.P., Distribution of HBsAg subtypes in the world, Vox Sang, 4: 197211, 1983.
  • 25
    Fiordalisi G., Ghiotto F., Castelnuovo F., Primi D., Cariani E., Analysis of the hepatitis B virus genome and immune response in HBsAG, anti-HBs positive chronic hepatitis, J. Hepatol., 4: 487493, 1994.
  • 26
    Brown S.E., Howard C.R., Zuckerman A.J., Steward M.W., Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides, Lancet, 2: 184187, 1984.
  • 27
    Ghany M.G., Ayola B., Villamil F.G., Gish R.G., Rojter S., Vierling J.M., Lok A.S., Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis, Hepatology, 1: 213222, 1998.
  • 28
    Ngui S.L., O' Connell S., Eglin R.P., Heptonstall J., Teo C.G., Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales, J. Infec. Dis., 5: 13601365, 1997.
  • 29
    Hsu H.Y., Chang M.H., Ni Y.H., Lin H.H., Wang S.M., Chen D.S., Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis, Hepatology, 3: 786791, 1997.
  • 30
    Oon C.J., Chen W.N., Goo K.S., Goh K.T., Intrafamilial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R, J. Infection., 3: 260264, 2000.
  • 31
    Mele A., Tancredi F., Romano L., Giuseppone A., Colucci M., Sangiuolo A., Lecce R., Adamo B., Tosti M.E., Taliani G., Zanetti A.R., Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy, J. Infect. Dis., 7: 905908, 2001.
  • 32
    Zhong S., Chan J.Y., Yeo W., Tam J.S., Johnson P.J., Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues, J. Viral Hep., 3: 195202, 1999.
  • 33
    He J.W., Lu Q., Zhu Q.R., Duan S.C., Wen Y.M., Mutations in the ‘a’ determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization, Vaccine, 2–3: 170173, 1998.
  • 34
    Kato J., Hasegawa K., Torii N., Yamauchi K., Hayashi N., A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B, Hepatology, 23: 391395, 1996.
  • 35
    Oon C.J., Chen W.N., Current aspects of hepatitis B surface antigen mutants in Singapore, J. Viral Hepatitis, 5: (Suppl. 2), 1723, 1998.
  • 36
    Schories M., Peters T., Rasenack J., Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection, J. Hepatol., 5: 799811, 2000.
  • 37
    Chirara M.M., Chetsanga C.J., Variant of hepatitis B virus isolated in Zimbabwe, J. Med. Virol., 42: 7378, 1994.
  • 38
    Oon C.J., Lim G.K., Ye Z., Goh K.T., Tan K.L., Yo S.L., Hopes E., Harrison T.J., Zuckerman A.J., Molecular epidemiology of hepatitis B virus vaccine variants in Singapore, Vaccine, 8: 699702, 1995.
  • 39
    Shields P.L., Owsianka A., Carman W.F., Boxall E., Hubscher S.G., Shaw J., O'Donnell K., Elias E., Mutimer D.J., Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function, Gut, 2: 306309, 1999.
  • 40
    Brind A., Jiang J., Samuel D., Gigou M., Feray C., Brechot C., Kremsdorf D., Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection, J. Hepatol., 2: 228235, 1997.
  • 41
    Protzer-Knolle U., Naumann U., Bartenschlager R., Berg T., Hopf U., Meyer zum Büschenfelde K.H., Neuhaus P., Gerken G., Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation, Hepatology, 1: 254263, 1998.
  • 42
    Seddigh-Tonekaboni S., Lim W.L., Young B., Hou J.L., Waters J., Luo K.X., Thomas H.C., Karayiannis P., Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient, J.Viral.Hepat., 2: 154158, 2001.
  • 43
    Oon C.J., Chen W.N., Lim N., Koh S., Lim G.K., Leong A.L., Tan G.S., Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ‘a’ epitope of the surface antigen are sensitive to ganciclovir, Antiviral Researche, 3: 113118, 1999.
  • 44
    Sterneck M., Kalinina T., Günther S., Fischer L., Santantonio T., Greten H., Will H., Functional analysis of HBV genomes from patients with fulminant hepatitis, Hepatology, 5: 13901397, 1998.
  • 45
    Moraes M.T.B., Gomes S.A., Niel C., Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil, Arch. Virol. 141: 17671773, 1996.
  • 46
    Ho M.S., Lu C.F., Kuo J., Mau Y.C., Chao W.H., A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children, Clin. Diagn. Lab. Immunol., 2: 760762, 1995.
  • 47
    Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., Okamoto H., Miyakawa Y., Mayumi M., Naturally occurring escape mutants of heptatitis B virus with various mutations in the S gene in carriers seropostive for antibody to hepatitis B surface antigen, J. Virol., 4: 26712676, 1994.
  • 48
    Yoshida E.M., Ramji A., Erb S.R., Davis J.E., Steinbrecher U.P., Sherlock C.H., Scudamore C.H., Chung S.W., Williams M., Gutfreund K.S., De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the “a” determinant, Liver, 5: 411114, 2000.
  • 49
    Karthigesu V., Allison L., D'Mello F., Fortuin M., Whittle H., Howard C.R., Breakthrough infections among children immunized against hepatitis B due to a novel variant (Abstract), La Jolla, CA: 1992. Meeting on Molecular Biology of Hepatitis B Viruses.
  • 50
    Rodriguez-Frias F., Buti M., Jardi R., Vargas V., Quer J., Cotrina M., Martell M., Esteban R., Guardia J., Genetic alternations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation, Liver, 3: 177182, 1999.
  • 51
    Carman W.F., Wallace L., Carulla J., McPhee R., Decker R., Natural occurance of arginine at aa 145 of HBsAg undetected by current assays causing fulminant hepatitis [Abstract 773] International Symposium on Viral Hepatitis and Liver Disease, 289, 1993.
  • 52
    Solomon L.R., Suhar T., Decker R., Okasinski G., Mimms L., Novel insertional S gene mutant in a fulminant hepatitis patient [Abstact 79]. Molecular biology of hepatitis B viruses, Washington D.C : Georgetown University Press, 1993.
  • 53
    Chong-Jin O., Wei Ning C., Shiuan K., Gek Keow L., Identification of hepatitis B surface antigen variants with alterations outside the “a” determinant in immunized Singapore infants, J. Infect. Dis., 1: 259263, 1999.
  • 54
    Blum H.E., Hepatitis B virus: Significance of naturally occurring mutants, Intervirology, 35: 4050, 1993.
  • 55
    Ngui S.L., Andrews N.J., Underhill G.S., Heptonstall J., Teo C.G., Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors, Clin. Infect. Dis., 1: 100106, 1998.
  • 56
    Lelie P.N., Ip H.M.H., Reesnik H.W., Wong V.C.W., Kuhns M.C., Prevention of the hepatitis B virus carrier state in infants of mothers with high and low serum levels of HBV-DNA. In:HollingerF.B., LemonS.M., MargolisH.S., eds., Viral hepatitis and liver disease, Baltimore : Williams & Wilkins, 1991, pp. 753756.
  • 57
    Carman W.F., Trautwein C., van Deursen F.J., Colman K., Dornan E., McIntyre G., Waters J., et al, Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis, Hepatology, 24: 489493, 1996.
  • 58
    Tai P., Banik D., Lin G., Pai S., Pai K., Lin M.H., Yuoh G., et al, Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class-I restricted T-cell epitope of the surface antigen, J. Virol., 71: 48524856, 1997.
  • 59
    Yap I., Chan S.H., A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: A preliminary observation, Ann. Acad. Med. Singapore, 1: 120122, 1996.
  • 60
    Yap I., Guan R., Chan S.H., Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines, J. Gastroenterol. Hepatol., 1: 5155, 1995.
  • 61
    Fernholz D., Galle P.R., Stemler M., Brunetto M., Bonino F., Will H., Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier, Virology, 194: 137148, 1993.
  • 62
    Trautwein C., Schrem H., Tillmann H.L., Kubicka S., Walker D., Böker K.H.W., Maschek H.J., Pichlmayr R., Manns M.P., Hepatitis B virus mutations in the pre-S genome before and after liver transplantation, Hepatology, 3: 482488, 1996.
  • 63
    Melegari M., Scaglioni P.P., Wands J.R., The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted, J. Virol., 7: 54495454, 1997.
  • 64
    Budkowska A., Bedossa P., Groh F., Louise A., Pillot J., Fibronectin of human liver sinusoids binds hepatitis B virus: Identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain, J. Virol., 2: 840848, 1995.
  • 65
    Le Seyec J., Chouteau P., Cannie I., Guguen-Guillouzo C., Gripon P., Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity, J. Virol., 7: 55735578, 1998.
  • 66
    Bruss V., A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation, J. Virol., 12: 93509357, 1997.
  • 67
    Gerner P.R., Friedt M., Oettinger R., Lausch E., Wirth S., The hepatitis B virus seroconversion to anti-Hbe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children, Virology, 1: 163172, 1998.
  • 68
    Hawkins A.E., Gilson R.J.C., Bickerton E.A., Tedder R.S., Weller I.V.D., Conservation of precore and core sequences of hepatitis B virus in chronic viral carriers, J. Med. Virol., 43: 512, 1994.
  • 69
    Schödel F., Peterson D., Zheng J., Jones J.E., Hughes J.L., Milich D.R., Structure of hepatitis B virus core and e-antigen, J. Biol. Chem., 2: 13321337, 1993.
  • 70
    Takahashi K., Kishimoto S., Ohori K., Yoshizawa H., Machida A., Ohnuma H., Tsuda F., Munekata E., Miyakawa Y., Mayumi M., Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus, J. Immunol., 9: 31563160, 1991.
  • 71
    Junker-Niepmann M., Bartenschlager R., Schaller H., A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA, Embo J., 9: 33893396, 1990.
  • 72
    Tavis J.E., Perri S., Ganem D., Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer, J. Virol., 6: 35363543, 1994.
  • 73
    Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R.I., Imai M., Miyakawa Y., Mayumi M., Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes, J. Gen. Virol., 69: 25752583, 1988.
  • 74
    Norder H., Couroucé A.M., Magnius L.O., Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes, Virology, 198: 489503, 1994.
  • 75
    Stuyver L., de Gendt S., van Geyt C., Zoulim F., Fried M., Schinazi R.F., Rossau R., A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, J. Gen. Virol., 1: 6774, 2000.
  • 76
    Stuyver L., de Gendt S., van Geyt C., Zoulim F., Fried M., Schinazi R.F., Rossau R., Characterization of a new hepatitis B virus: complete genome and phylogenetic relatedness, J. Gen. Virol., in press.
  • 77
    Stuyver L., van Geyt C., de Gendt S., van Reybroeck G., Zoulim F., Leroux-Roels G., Rossau R., Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy, J. Clin. Microbiol., 2: 702707, 2000.
  • 78
    Friedt M., Gerner P., Lausch E., Trbel H., Zabel B., Wirth S., Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B, Hepatology, 4: 12521258, 1999.
  • 79
    Niitsuma H., Ishii M., Saito Y., Miura M., Kobayashi K., Ohori H., Toyota T., Prevalence of precore-defective mutant of hepatitits B virus in HBV carriers, J. Med. Virol., 46: 397402, 1995.
  • 80
    Ulrich P.P., Bhat R.A., Kelly I., Brunetto M.R., Bonino F., Vyas G.N., A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease, J. Med. Virol., 32: 109118, 1990.
  • 81
    Yuan T.T.T., Faruqi A., Shih J.W.K., Shih C., The mechanism of natural occurrence of two closely linked HBV precore predominant mutations, Virology, 211: 144156, 1995.
  • 82
    Rodriguez-Frias F., Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R., Guardia J., Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations, Hepatology, 6: 16411647, 1995.
  • 83
    Guo Y., Hou J., Luo K., Feng X., Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro, Zhonghua Gan Zang Bing Za Zhi, 1: 4244, 2001.
  • 84
    Günther S., Meisel H., Reip A., Miska S., Krüger D.H., Will H., Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment, Virology, 187: 271279, 1992.
  • 85
    Carman W.F., Jacyna M.R., Hadziyannis S., Karayiannis P., McGarvey M.J., Makris A., Thomas H.C., Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection, Lancet, 2: 588591, 1989.
  • 86
    Kramvis A., Kew M.C., Bukofzer S., Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma, J. Hepatol., 1: 132141, 1998.
  • 87
    Okamoto H., Yotsumoto S., Akahane Y., Yamanaka T., Miyazaki Y., Sugai Y., Tsuda F., Tanaka T., Miyakawa Y., Mayumi M., Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen, J. Virol., 3: 12981303, 1990.
  • 88
    Omi S., Okamoto H., Tsuda F., Mayumi M., Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chimpanzees, J. Gastroenterol. Hepatol., 6: 646652, 1990.
  • 89
    Akahane Y., Yamanaka T., Suzuki H., Sugai Y., Tsuda F., Yotsumoto S., Omi S., Okamoto H., Miyakawa Y., Mayumi M., Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region, Gastoenterol., 4: 11131119, 1990.
  • 90
    Brunetto M.R., Stemler M., Bonino F., Schodel F., Oliveri F., Rizzetto M., Verme G., Will H., A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B, J. Hepatol., 2: 258261, 1990.
  • 91
    Naoumov N.V., Schneider R., Groetzinger T., Jung M.C., Miska S., Pape G.R., Will H., Precore mutant hepatitis B virus infection and liver disease, Gastroenterology, 2: 538543, 1992.
  • 92
    Inoue K., Yoshiba M., Sekiyama K., Okamoto H., Mayumi M., Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus, J. Med. Virol., 1: 3541, 1998.
  • 93
    Hasegawa K., Huang J., Rogers S.A., Blum H.E., Liang T.J., Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis, J. Virol., 3: 16511659, 1994.
  • 94
    Kosaka Y., Takase K., Kojima M., Shimizu M., Inoue K., Yoshiba M., Tanaka S., Akahane Y., Okamoto H., Tsuda F., et al., Fulminant hepatitis B: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen, Gastroenterology, 4: 10871094, 1991.
  • 95
    Liang T.J., Hasegawa K., Rimon N., Wands J.R., Ben-Porath E., A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis (see comments), N. Engl. J. Med., 24: 17051709, 1991.
  • 96
    Omata M., Ehata T., Yokosuka O., Hosoda K., Ohto M., Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis (see comments), N. Engl. J. Med., 24: 16991704, 1991.
  • 97
    Fujise K., Suzuki K., Naito Y., Niiya M., Ishikawa T., Takahashi H., Hoshina S., Saito A., Watanabe R., Hepatitis B virus variants in patients with acute hepatitis in whom various clinical forms develop, Kansenshogaku Zasshi, J. Japan. Association Infect. Dis., 1: 6774, 1998.
  • 98
    Ito S., Nakazono K., Murasawa A., Mita Y., Hata K., Saito N., Kikuchi M., Yoshida K., Nakano M., Gejyo F., Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient, Arthritis and Rheumatism, 2: 339342, 2001.
  • 99
    Karasawa T., Aizawa Y., Zeniya M., Kuramoto A., Shirasawa T., Toda G., Genetic heterogeneity in the precore region of hepatitits B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion, J. Med. Virol., 45: 373380, 1995.
  • 100
    Nakahori S., Yokosuka O., Ehata T., Chuang W. L., Imazeki F., Ito Y., Ohto M., Detection of hepatitis B virus precore stop codon mutants by selective amplification method: Frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers, J. Gastroenterol. Hepatol., 4: 419425, 1995.
  • 101
    Laskus T., Persing D.H., Nowicki M.J., Mosley J.W., Rakela J., Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States, Gastroenterology, 4: 11731178, 1993.
  • 102
    Naumann U., Protzer-Knolle U., Berg T., Leder K., Lobeck H., Bechstein W.O., Gerken G., Hopf U., Neuhaus P., A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis, Hepatology, 2: 478484, 1997.
  • 103
    Dienes H.P., Gerken G., Goergen B., Heermann K., Gerlich W., Meyer zum Büschenfelde K.H., Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis B e-positive chronic hepatitis, Hepatology, 1: 17, 1995.
  • 104
    Zhong S., Chan J.Y., Yeo W., Tam J.S., Johnson P.J., Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues, J. Viral Hepatitis, 2: 115123, 2000.
  • 105
    Ackrill A.M., Naoumov N.V., Eddleston A.L., Williams R., Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection, J. Hepatol., 1-2: 224227, 1992.
  • 106
    Schlicht H.J., Wasenauer G., The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence, J. Virol., 12: 68176825, 1991.
  • 107
    Wasenauer G., Köck J., Schlicht H.J., Relevance of cysteine residues for biosynthesis and antigenicity of human hepatitis B virus e protein, J. Virol., 3: 13151321, 1993.
  • 108
    Clementi M., Manzin A., Paolucci S., Menzo S., Bagnarelli P., Carloni G., Bearzi I., Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues, Res. Virol., 4: 2973011993.
  • 109
    Manzin A., Menzo S., Bagnarelli P., Varaldo P.E., Bearzi I., Carloni G., Galibert F., Clementi M., Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients, Virology, 2: 890895, 1992.
  • 110
    Triki H., Ben Slimane S., Ben Mami N., Sakka T., Ben Ammar A., Dellagi K., High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa, Epidemiol. Infect., 1: 169174, 2000.
  • 111
    Nassal M., Junker-Niepmann M., Schaller H., Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly, Cell., 6: 13571363, 1990.
  • 112
    Birnbaum F., Nassal M., Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein, J. Virol., 7: 33193330, 1990.
  • 113
    Nassal M., The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly, J. Virol., 7: 41074116, 1992.
  • 114
    Missale G., Redeker A., Person J., Fowler P., Guilhot S., Schlicht H.J., Ferrari C., Chisari F.V., HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis, J. Exp. Med., 3: 751762, 1993.
  • 115
    Bertoletti A., Chisari F.V., Penna A., Guilhot S., Galati L., Missale G., Fowler P., Schlicht H.J., Vitiello A., Chesnut R.C., et al., Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein, J. Virol., 4: 23762380, 1993.
  • 116
    Bertoletti A., Ferrari C., Fiaccadori F., Penna A., Margolskee R., Schlicht H.J., Fowler P., Guilhot S., Chisari F.V., HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen, Proc. Natl. Acad. Sci. USA, 23: 1044510449, 1991.
  • 117
    Penna A., Bertoletti A., Cavalli A., Valli A., Missale G., Pilli M., Marchelli S., Giuberti T., Fowler P., Chisari F.V., Fiaccadori F., Ferrari C., Fine specificity of the human T cell response to hepatitis B virus core antigen, Arch. Virol. Suppl., 4: 2328, 1992.
  • 118
    Ehata T., Omata M., Yokosuka O., Hosoda K., Ohto M., Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection, J. Clin. Invest., 89: 332338, 1992.
  • 119
    Salfeld J., Pfaff E., Noah M., Schaller H., Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus, J. Virol., 2: 798808, 1989.
  • 120
    McMillian J.S., Bowden D.S., Angus P.W., McCaughan G.W., Locarnini S.A., Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation, Hepatology, 6: 13711378, 1996.
  • 121
    Milich D.R., McLachlan A., Moriarty A., Thornton G.B., Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg, J. Immunol., 4: 12231231, 1987.
  • 122
    Milich D.R., McLachlan A., Stahl S., Wingfield P., Thornton G.B., Hughes J.L., Jones J.E., Comparative immunogenicity of hepatitis B virus core and E antigens, J. Immunol., 10: 36173624, 1988.
  • 123
    Carman W., Thomas H., Domingo E., Viral genetic variation: hepatitis B virus as a clinical example, Lancet, 341: 349353, 1993.
  • 124
    Wakita T., Kakumu S., Shibata M., Yoshioka K., Ito Y., Shinagawa T., Ishikawa T., Takayanagi M., Morishima T., Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers, J. Clin. Invest., 6: 17931801, 1991.
  • 125
    Maini M.K., Reignat S., Boni C., Ogg G.S., King A.S., Malacarne F., Webster G.J., Bertoletti A., T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection, Europ. J. Immunol., 11: 30673078, 2000.
  • 126
    Ehata T., Omata M., Chuang W.L., Yokosuka O., Ito Y., Hosoda K., Ohto M., Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis, J. Clin. Invest., 3: 12061213, 1993.
  • 127
    Chuang W.L., Omata M., Ehata T., Yokosuka O., Ito Y., Imazeki F., Lu S.N., Chang W.Y., Ohto M., Precore mutations and core clustering mutations in chronic hepatitis B virus infection, Gastroenterology, 1: 263271, 1993.
  • 128
    Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., de Carli M., Fiaccadori F., Ferrari C., Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells, Nature, 369: 407410, 1994.
  • 129
    Günther S., Paulij W., Meisel H., Will H., Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity, Virology, 1: 146160, 1998.
  • 130
    Rehermann B., Pasquinelli C., Mosier S.M., Chisari F.V., Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection, J. Clin. Invest., 96: 15271534, 1995.
  • 131
    Alexopoulou A., Karayiannis P., Hadziyannis S.J., Aiba N., Thomas H.C., Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species, J. Hepatol., 26: 748753, 1997.
  • 132
    Stuyver L., de Gendt S., Cadranel J.F., van Geyt C., van Reybroeck G., Dorent R., Gandjbachkh I., Rosenheim M., Charlotte F., Opolon P., Huraux J.M., Lunel F., Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus, Hepatology, 6: 18761883, 1999.
  • 133
    Aye T.T., Uchida T., Becker S.O., Hirashima M., Shikata T., Komine F., Moriyama M., Arakawa Y., Mima S., Mizokami M., Variations of hepatitis B virus precore/core gene sequences in acute and fulminant hepatitis B, Dig. Dis. Sci., 6: 12811287, 1994.
  • 134
    Saellberg M., Ruden U., Wahren B., Noah M., Magnius L.O., Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant, Mol. Immunol., 7: 719726, 1991.
  • 135
    Yuan T.T.T., Tai P.C., Shih C., Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen, J. Virol., 73: 1012210128, 1999.
  • 136
    Yuan T.T., Shih C., A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L), J. Virol., 10: 49294932, 2000.
  • 137
    Marinos G., Torre F., Günther S., Thomas M.G., Will H., Williams R., Naoumov N.V., Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection, Gastroenterology, 1: 183192, 1996.
  • 138
    Yuan T.T., Lin M.H., Qiu S.M., Shih C., Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation, J. Virol., 3: 21682176, 1998.
  • 139
    Fouillot N., Tiouzeau S., Rossignol J.M., Jean-Jean O., Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation, J. Virol., 8: 48864895, 1993.
  • 140
    Scaglioni P.P., Melegari M., Wands J.R., Characterization of hepatitis B virus core mutants that inhibit viral replication, Virology, 1: 112120, 1994.
  • 141
    Preikschat P., Meisel H., Will H., Günther S., Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions, J. Gen. Virol., 10: 26852691, 1999.
  • 142
    Pult I., Chouard T., Wieland S., Klemenz R., Yaniv M., Blum H.E., A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B, Hepatology, 25: 15071515: 1997.
  • 143
    Okamoto H., Wang Y., Tanaka T., Machida A., Miyakaw Y., Mayumi M., Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines, J. Gen. Virol., 74: 407414, 1993.
  • 144
    Roingeard P., Romet-Lemonne J.L., Leturcq D., Goudeau A., Essex M., Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect, Virology, 1: 113120, 1990.
  • 145
    Chisari F.V., Filippi P., Buras J., McLachlan A., Popper H., Pinkert C.A., Palmiter R.D., Brinster R.L., Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice, Proc. Natl. Acad. Sci. USA, 19: 69096913, 1987.
  • 146
    Lenhoff R.J., Summers J., Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in pimary hepatocytes, J. Virol., 9: 57065713, 1994.
  • 147
    Milich D.R., Jones J.E., Hughes J.L., Price J., Raney A.K., McLachlan A., Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero Proc. Natl. Acad. Sci. USA, 17: 65996603, 1990.
  • 148
    Tsai S.L., Chen P.J., Lai M.Y., Yang P.M., Sung J.L., Huang J.H., Hwang L.H., Chang T.H., Chen D.S., Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion, J. Clin. Invest. 1: 8796, 1992.
  • 149
    Marinos G., Torre F., Chokshi S., Hussain M., Clarke B.E., Rowlands D.J., Eddleston A.L., Naoumov N.V., Williams R., Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus, Hepatology, 4: 10401049, 1995.
  • 150
    Fattovich G., McIntyre G., Thursz M., Colman K., Giuliano G., Alberti A., Thomas H.C., Carman W.F., Hepatitis B virus precore/core variation and interferon therapy, Hepatology, 5: 13551362, 1995.
  • 151
    Takeda K., Akahane Y., Suzuki H., Okamoto H., Tsuda F., Miyakawa Y., Mayumi M., Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy, Hepatology, 6: 12841289, 1990.
  • 152
    Loriot M. A., Marcellin P., Talbodec N., Guigonis V., Gigou M., Boyer N., Bezeaud A., Erlinger S., Benhamou J.P., Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B, Hepatology, 3: 627631, 1995.
  • 153
    Grandjacques C., Pradat P., Stuyver L., Chevallier M., Chevallier P., Pichoud C., Maisonnas M., Trepo C., Zoulim F., Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity, J. Hepatol., 3: 430439, 2000.
  • 154
    Brunetto M.R., Oliveri F., Demartini A., Calvo P., Manzini P., Cerenzia M.T., Bonino F., Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen, J. Hepatol., 1: 811, 1991.
  • 155
    Maruyama T., Kuwata S., Koike K., Iino S., Yasuda K., Yotsuyanagi H., Moriya K., Maekawa H., Yamada H., Shibata Y., Milich D.R., Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion, Hepatology, 1: 245253, 1998.
  • 156
    Lok A.S.F., Akarca U.S., Greene S., Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance, Hepatology, 1: 1924, 1995.
  • 157
    Brook M.G., Karayiannis P., Thomas H.C., Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors (see comments), Hepatology, 5: 761763, 1989.
  • 158
    Kumar V., Jayasuryan N., Kumar R., A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function, Proc. Natl. Acad. Sci. USA, 93: 56475652, 1996.
  • 159
    Kekulé A.S., Lauer U., Weiss L., Luber B., Hofschneider P.H., Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway, Nature, 361: 742745, 1993.
  • 160
    Hohne M., Schaefer S., Seifer M., Feitelson M.A., Paul D., Gerlich W.H., Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA, Embo J., 4: 11371145, 1990.
  • 161
    Kim C.M., Koike K., Saito I., Miyamura T., Jay G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice, Nature, 351: 317320, 1991.
  • 162
    Seifer M., Hohne M., Schaefer S., Gerlich W.H., In vitro tumorigenicity of hepatitis B virus DNA and HBx protein, J. Hepatol., 13: (Suppl. 4), 6165, 1991.
  • 163
    Murakami S., Cheong J.H., Kaneko S., Human hepatitis virus X gene encodes a regulatory domain that repesses transactivation of X protein, J. Biol. Chem., 21: 1511815123, 1994.
  • 164
    Faktor O., Shaul Y., The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax, Oncogene, 5: 867872, 1990.
  • 165
    Seto E., Mitchell P.J., Yen T.S., Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors, Nature, 344: 7274, 1990.
  • 166
    Wu J.Y., Zhou Z.Y., Judd A., Cartwright C.A., Robinson W.S., The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase, Cell, 4: 687695, 1990.
  • 167
    Natoli G., Avantaggiati M.L., Chirillo P., de Marzio E., Collepardo D., Falco M., Balsano C., Levrero M., Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX, J. Hepatol., 22: (Suppl. 1), 1420, 1995.
  • 168
    Cheong J.H., Yi M.K., Lin Y., Murakami S., Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation, Embo J., 1: 143150, 1995.
  • 169
    Haviv I., Shamay M., Doitsh G., Shaul Y., Hepatitis B virus pX targets TFIIB in transcription coactivation, Mol. Cell. Biol., 3: 15621569, 1998.
  • 170
    Lin Y., Nomura T., Cheong J., Dorjsuren D., Iida K., Murakami S., Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5, J. Biol. Chem., 11: 71327139, 1997.
  • 171
    Oadri I., Maguire H.F., Siddiqui A., Hepatitis B virus transactivator protein x interacts with the TATA-binding protein, Pro. Natl. Acad. Sci. USA, 4: 10031007, 1995.
  • 172
    Maquire H.F., Hoeffler J.P., Siddiqui A., HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions, Science, 252: 842844, 1991.
  • 173
    Unger T., Shaul Y., The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element, Embo J., 6: 1889189, 1905.
  • 174
    Becker S.A., Lee T.H., Butel J.S., Slagle B.L., Hepatitis B virus X protein interferes with cellular DNA repair, J. Virol., 1: 266272, 1998.
  • 175
    Feitelson M., Lega L., Guo J., Resti M., Rossi M.E., Azzari C., Blumberg B.S., Vierucci A., Pathogenesis of posttransfusion viral hepatitis in children with b-thalassemia, Hepatology, 3: 558568, 1994.
  • 176
    Honda A., Yokosuka O., Suzuki K., Saisho H., Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection, J. Med. Virol., 2: 167176, 2000.
  • 177
    Li J., Buckwold V.E., Hon M.W., Ou J.H., Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation, J. Virol., 73: 12391244, 1999.
  • 178
    Uchida T., Gotoh K., Shikata T., Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B, J. Med. Virol., 45: 247252, 1995.
  • 179
    Uchida T., Shimojima M., Gotoh K., Shikata T., Tanaka E., Kiyosawa K., “Silent” hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis, Microbiol. Immunol., 4: 281285, 1994.
  • 180
    Hsia C.C., Nakashima Y., Tabor E., Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma, Biochem. Biophys. Res. Commun., 3: 726729, 1997.
  • 181
    Rho H.M., Kim K., Hyun S.W., Kim Y.S., The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr, Nucleic. Acids. Res., 5: 2124, 1989.
  • 182
    Kim S.H., Hong S.P., Kim S.K., Lee W.S., Rho H.M., Replication of a mutant hepatitis B virus with a fused X-C reading frame in hepatoma cells, J. Gen. Virol., 73: 24212424, 1992.
  • 183
    Repp R., Keller C., Borkhardt A., Csecke A., Schaefer S., Gerlich W.H., Lampert F., Detection of a hepatitis B virus variant with a truncated X gene and enhancer II, Arch. Virol., 125: 299304, 1992.
  • 184
    Dejean A., Sonigo P., Wain-Hobson S., Tiollais P., Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat, Proc. Natl. Acad. Sci. USA, 17: 53505354, 1984.
  • 185
    Shaul Y., Ziemer M., Garcia P.D., Crawford R., Hsu H., Valenzuela P., Rutter W.J., Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line, J. Virol., 3: 776787, 1984.
  • 186
    Feitelson M.A., Duan L.X., Guo J., Horiike N., McIntyre G., Blumberg B.S., Thomas H.C., Carman W., Precore and X region mutants in hepatitis B virus infections among renal dialysis patients, J. Viral Hepat., 1: 1931, 1995.
  • 187
    Laskus T., Rakela J., Tong M.J., Nowicki M.J., Mosley J.W., Persing D.H., Naturally occurring hepatitis B virus mutants with deletion in the core promoter region, J. Hepatol., 6: 837841, 1994.
  • 188
    Feitelson M.A., Duan L.X., Guo J., Blumberg B.S., X region deletion mutants associated with surface antigen-positive hepatitis B virus infections, Gastroenterology, 6: 18101819, 1995.
  • 189
    Blum H.E., Zhang Z.S., Galun E., von Weizsaecker F., Garner B., Liang T.J., Wands J.R., Hepatitis B virus X protein is not central to the viral life cycle in vitro, J. Virol., 2: 12231227, 1992.
  • 190
    Moriyama K., Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter, J. Gen. Virol., 6: 14791486, 1997.
  • 191
    Honigwachs J., Faktor O., Dikstein R., Shaul Y., Laub O., Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer, J. Virol., 2: 919924, 1989.
  • 192
    Lopez-Cabrera M., Letovsky J., Hu K.Q., Siddiqui A., Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: transactivation and repression by CCAAT/enhancer binding protein, Proc. Natl. Acad. Sci. USA, 13: 50695073, 1990.
  • 193
    Lopez-Cabrera M., Letovsky J., Hu K.Q., Siddiqui A., Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitits B virus, Virology, 2: 825829, 1991.
  • 194
    Yee J.K., A liver-specific enhancer in the core promoter region of human hepatitis B virus, Science, 246: 4930, 658661, 1989.
  • 195
    Yuh C.H., Chang Y.L., Ting L.P., Transcriptional regulation of precore and pregenomic RNAs of hepatitits B virus, J. Virol., 7: 40734084, 1992.
  • 196
    Yuh C.H., Ting L.P., The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function, J. Virol., 9: 42814287, 1990.
  • 197
    Kaneko M., Uchida T., Moriyama M., Arakawa Y., Shikata T., Gotoh K., Mima S., Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B, J. Med. Virol., 47: 1995, 204208.
  • 198
    Ogata N., Miller R.H., Ishak K.G., Purcell R.H., The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees, Virology, 1: 263276, 1993.
  • 199
    Honda A., Yokosuka O., Ehata T., Tagawa M., Imazeki F., Saisho H., Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status, J. Med. Virol., 57: 337344, 1999.
  • 200
    Lindh M., Hannoun C., Dhillon A.P., Norkrans G., Horal P., Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers, J. Infect. Dis., 4: 775782, 1999.
  • 201
    Baumert T., Rogers S., Hasegawa K., Liang T., Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication, J. Clin. Invest., 98: 22682276, 1996.
  • 202
    Kao J.H., Wu N.H., Chen P.J., Lai M.Y., Chen D.S., Hepatitis B genotypes and the response to interferon therapy, J. Hepatol., 6: 9981002, 2000.
  • 203
    Buckwold V., Xu Z., Chen M., Yen S.B., Ou J.H., Effects of naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication, J. Virol., 70: 58455851, 1996.
  • 204
    Moriyama K., Okamoto H., Tsuda F., Mayumi M., Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigenseronegative persistent infections, Virology, 226: 269280, 1996.
  • 205
    Buckwold V.E., Xu Z., Yen T.S, Ou J.H., Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication, J. Gen. Virol., 78: 20552065, 1997.
  • 206
    Günther S., Piwon N., Iwanska A., Schilling R., Meisel H., Will H, Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease, J. Virol., 70: 83188331, 1996.
  • 207
    Günther S., Piwon N., Will H., Wild-type levels of pregenomic RNA and replication but reducet pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) T, A(1762) T and G(1764) A mutations in the core promoter, J. Gen. Virol., 79: 375380, 1998.
  • 208
    Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., et al., Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen, J. Virol., 68: 81028110, 1994.
  • 209
    Kurosaki M., Enomoto N., Asahina Y., Sakuma I., Ikeda T., Tozuka S., Izumi N., et al., Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B, J. Med. Virol., 49: 115123, 1996.
  • 210
    Orito E., Mizokami M., Sakugawa H., Michitaka K., Ishikawa K., Ichida T., Okanoue T., Yotsuyanagi H., Iino S., A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group, Hepatology, 1: 218223, 2001.
  • 211
    Chan H.L.Y., Hussain M., Lok A.S.F., Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion, Hepatology, 3: 976984, 1999.
  • 212
    Lanford R.E, Notvall L., Beames B., Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells, J. Virol., 7: 44314439, 1995.
  • 213
    Condreay L.D., Wu T.T., Aldrich C.E., Delaney M.A., Summers J., Seeger C., Mason W.S., Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis, Virology, 1: 208216, 1992.
  • 214
    Nagaya T., Nakamura T., Tokino T., Tsurimoto T., Imai M., Mayumi T., Kamino K., Yamamura K., Matsubara K., The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma, Genes. Dev., 1: 773782, 1987.
  • 215
    Hino O., Ohtake K., Rogler C.E., Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration, J. Virol., 6: 26382643, 1989.
  • 216
    Wang H.P., Rogler C.E., Topoisomerase I-mediated integration of hepadnavirus DNA in vitro, J. Virol., 5: 23812392, 1991.
  • 217
    Bartenschlager R., Schaller H., The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription, Embo J., 7: 41854192, 1988.
  • 218
    Chang L.J., Hirsch R.C., Ganem D., Varmus H.E., Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase, J. Virol., 11: 55535558, 1990.
  • 219
    Radziwill G., Tucker W., Schaller H., Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity, J. Virol., 2: 613620, 1990.
  • 220
    Saldanha J.A., Qiu H., Thomas H.C., Monjardino J., Mapping of 5' ends of virion-derived HBV DNA, Virology, 1: 358361, 1992.
  • 221
    Gerlich W.H., Robinson W.S., Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand, Cell, 3: 801809, 1980.
  • 222
    Zoulim F., Seeger C., Reverse transcription in hepatitis B viruses is primed by a tyrosine residus of the polymerase, J. Virol., 1: 613, 1994.
  • 223
    Wang G.H., Seeger C., Novel mechanism for reverse transcription in hepatitis B viruses, J. Virol., 11: 65076512, 1993.
  • 224
    Blum H.E., Galun E., Liang T.J., von Weizsaecker F., Wands J. R., Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication, J. Virol., 4: 18361842, 1991.
  • 225
    Poch O., Sauvaget I., Delarue M., Tordo N., Identification of four conserved motifs among the RNA-dependent polymerase encoding elements, Embo J., 8: 38673874, 1989.
  • 226
    Tipples G.A., Ma M.M., Fischer K.P., Bain V.G., Kneteman N.M., Tyrrell D.L.J., Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo, Hepatology, 3: 714717, 1996.
  • 227
    Liaw Y.F., Chein R.N., Yeh C.T., Tsai S.L., Chu C.M., Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy, Hepatology, 2: 567572, 1999.
  • 228
    Melegari M., Scaglioni P.P., Wands J.R., Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective, Hepatology, 2: 628633, 1998.
  • 229
    Ladner S.K., Miller T.J., King R.W., The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy- 3'- thiacytidine and a reduced ability to sythesize viral DNA, Antimicrob. Agents Chemother., 42: 21282131, 1998.
  • 230
    Fu, L., Cheng, Y.C., Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-) SddC (3TC) resistence Biochem. Pharmacol., 10: 15671572, 1998.
  • 231
    Allen M.I., Deslauriers M., Andrews C.W., et al., Identification and characterisation of mutations in hepatitis B virus resistant to lamivudine, Hepatology, 27: 16701677, 1998.
  • 232
    Mutimer D., Pillay D., Cook P., Ratcliffe D., O'Donnel K., Dowling D., Shaw J., Elias E., Cane P.A., Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy. J. Infect. Dis., 181: 713716, 2000.
  • 233
    de Man R.A., Bartholomeusz A.I., Niesters H.G., Zondervan P.E., Locarnini S.A., The sequential occurrence of viral mutations in a liver transplant receipient re-infected with hepatitis B: hepatitis B immune globulin escape, famiciclovir non-response, followed by lamivudine resistance resulting in graft loss, J. Hepatol., 4: 669675, 1998.
  • 234
    Cane P.A., Mutimer D., Ratcliffe D., Cook P., Beards G., Elias E., Pillay D., Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation, Antivir. Ther., 1: 714, 1999.
  • 235
    Pillay D., Bartholomeusz A., Cane P., et al., Mutations in the hepatitis B DNA polymerase associated with antiviral resistance, Int. Antiviral News, 6: 167169, 1998.
  • 236
    Bartholomeusz A., Schinazi R.F., Locarnini S., Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease, Viral. Hepat. Rev., (in press).
  • 237
    Aye T.T., Bartholomeusz A., Shaw T., Bowden S., Breschkin A., McMillan J., Angus P., Locarnini S., Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation, J. Hepatol., 26: 11481153, 1997.
  • 238
    Chayama K., Suzuki Y., Kobayashi M., Tsubota A., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I., Arase Y., Saitoh S., Murashima N., Ikeda K., Kumada H., Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and retakeover by wild type after cessation of therapy, Hepatology, 6: 17111716, 1998.
  • 239
    Seta T., Yokosuka O., Imazeki F., Tagawa M., Saisho H., Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients, J. Med. Virol., 1: 816, 2000.
  • 240
    Ling R., Mutimer D., Ahmed M., Boxall E.H., Elias E., Dusheiko G.M., Harrison T.J., Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine, Hepatology, 3: 711713, 1996.
  • 241
    Peters M.G., Singer F., Howard T., Jacobsmeyer S., Xiong X., Gibbs C.S., Lamy P., Murray A., Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin, Transplantation, 12: 19121914, 1999.
  • 242
    Chen Y., Robinson W.S., Marion P.L., Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging, J. Virol., 2: 12821287, 1992.
  • 243
    Rehermann B., Fowler P., Sidney J., Person J., Redeker A., Brown M., Moss B., Sette A., Chisari F.V., The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis, J. Exp. Med., 181: 10471058, 1995.
  • 244
    Grellier L., Mutimer D., Ahmed M., Brown D., Burroughs A.K., Rolles K., McMaster P., Beranek P., Kennedy F., Kibbler H., McPhillips P., Elias E., Dusheiko G., Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis, Lancet, 348: 12121215, 1996.
  • 245
    Centers for Disease Control, Recommendations of the Immunisation Practices Advisory Committee, Recommendations for protection against viral hepatitis, MMWR, 34: 329335, 1985.
  • 246
    International Group, Immunisation against hepatitis B, Lancet, 1: 875876, 1998.
  • 247
    World Health Organization, Informal consultation on quadrivalent diptheria-tetanus-pertussis-hepatitis B vaccine: final report, Geneva : WHO, 1992.
  • 248
    European consensus group on hepatitis B immunity, Are booster immunisations needed for lifelong hepatitis B immunity Lancet, 355: 561565, 2000.
  • 249
    Lee P.I., Lee C.Y., Huang L.M., Chang M.H., Longterm efficacy of recombinant hepatitis B vaccine and risk of infection in infants born to mothers with hepatitis B e antigen, Pediatrics, 126: 716721, 1995.
  • 250
    Beasley R.P., Hwang L.Y., Overview on the epidemiology of hepatocellular carcinoma. In; HollingerF.B., LemonS.M., MargolisH., eds., Viral hepatitis and liver disease, Baltimore ; Williams & Wilkins, 1991, pp. 532535.
  • 251
    Zuckerman A.J., Harrison T.J., Oon C.J., Mutations in the S region of hepatitis B virus, Lancet, 343: 737738, 1994.
  • 252
    Coleman P.F., Chen Y.C.J., Mushahwar I.K., Immunoassay detection of hepatitis B surface antigen mutants, J. Med. Virol., 1: 1924, 1999.
  • 253
    Chen W.N., Oon C.J., Koh S., Horizontal transmission of a hepatitis B virus surface antigen mutant, J. Clin. Microbiol., 2: 938939. 2000.
  • 254
    Ijaz S., Torre F., Tedder R.S., Williams R., Naoumov N.V., Novel immunoassay for the detection of hepatitis B surface ‘escape’ mutants and its application in liver transplant recipients, J. Med. Virol., 3: 210216, 2001.
  • 255
    Mushahwar I.K., Brawner T., Radioimmunoassays. In: SpectorS., LanczG., Eds., Clinical virology manual. 2nd Ed. New York : Elsevier, 1992, pp. 129151.
  • 256
    Li J.S., Tong S.P. Vitvitski L., Zoulim F., Trépo C., Rapid detection and further characterization of infection with hepatitis B virus variants containing a stop codon in the distal pre-C region, J. Gen. Virol., 71: 19931998, 1990.
  • 257
    Gramegna M., Lampertico P., Lobbiani A., Colucci G., Detection of the hepatitis B virus major pre-core mutation by the amplification refractorymutation system technique, Res. Virol., 144: 307309. 1993.
  • 258
    Lindh M., Furuta Y., Ljunggren K.K., Norkrans G., Horal P., Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method, J. Infect. Dis., 171: 194197, 1995.
  • 259
    Whalley S.A., Brown D., Teo C.G., Dusheiko G.M., Saunders N.A., Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler, J. Clin. Microbiol., 4: 14561459, 2001.